Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 3/20 | 0.60 |
| ▸ | CA2 | P00918 | 3/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.54 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.54 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | CES1 | P23141 | 1/20 | 0.53 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.51 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.51 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.51 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Anisic Acid SCHEMBL30857728 | 0.93 | CA1 (0.65) | MAPTNPC1RAB9ASMN1; SMN2CA1 | |
| SCHEMBL15762824 | 0.91 | MAPT (0.54) | MAPTNPC1RAB9ASMN1; SMN2CA1 | |
| SCHEMBL11985689 | 0.90 | MAPT (0.73) | MAPTNPC1RAB9ASMN1; SMN2CA1 | |
| SCHEMBL20073174 | 0.89 | SMN1; SMN2 (0.59) | MAPTNPC1RAB9ASMN1; SMN2CA1 | |
| SCHEMBL18668887 | 0.88 | SMN1; SMN2 (0.57) | MAPTNPC1RAB9ASMN1; SMN2CA1 | |
| SCHEMBL27824110 | 0.87 | SMN1; SMN2 (0.64) | MAPTNPC1RAB9ASMN1; SMN2CA1 | |
| SCHEMBL26378 | 0.86 | TDP1 (0.56) | MAPTNPC1RAB9ASMN1; SMN2CA1 | |
| SCHEMBL1988247 | 0.85 | TSHR (0.68) | MAPTNPC1RAB9ASMN1; SMN2CA1 | |
| SCHEMBL12532605 | 0.85 | NPC1 (0.67) | MAPTNPC1RAB9ASMN1; SMN2CA1 | |
| SCHEMBL13256587 | 0.85 | SMN1; SMN2 (0.62) | MAPTNPC1RAB9ASMN1; SMN2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230134686-A1 | COMPOSITIONS CONTAINING BENZOIC ACID OR FUROIC ACID DERIVATIVES AND USE OF THE DERIVATIVES FOR EMULSION AND FOAM STABILITY | SYMRISE AG (DE) | 2023-05-04 | — | — | US | disclosed |
| US-20230134686-A1 | COMPOSITIONS CONTAINING BENZOIC ACID OR FUROIC ACID DERIVATIVES AND USE OF THE DERIVATIVES FOR EMULSION AND FOAM STABILITY | SYMRISE AG (DE) | 2023-05-04 | — | — | US | disclosed |
| US-11116710-B2 | Antimicrobial compositions | SYMRISE AG (DE) | 2021-09-14 | — | — | US | disclosed |
| US-20190282478-A1 | ANTIMICROBIAL COMPOSITIONS | SYMRISE AG (DE) | 2019-09-19 | — | — | US | disclosed |
| WO-2019072375-A1 | COMPOSITIONS CONTAINING BENZOIC ACID OR FUROIC ACID DERIVATIVES AND USE OF THE DERIVATIVES FOR EMULSION AND FOAM STABILITY | SYMRISE AG (DE) | 2019-04-18 | — | — | WO | disclosed |
| WO-2018068825-A1 | ANTIMICROBIAL COMPOSITIONS | SYMRISE AG (DE) | 2018-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190282478-A1 | ANTIMICROBIAL COMPOSITIONS | MPO, NHERF1, NOX1 | MAPT 3060/4885NPC1 181/4885RAB9A 3253/4885 |
| US-20230134686-A1 | COMPOSITIONS CONTAINING BENZOIC ACID OR FUROIC ACID DERIVATIVES AND USE OF THE DERIVATIVES FOR EMULSION AND FOAM STABILITY | SDHA, SDHB, FABP4 | MAPT 2551/4885NPC1 1336/4885RAB9A 3423/4885 |
| US-11116710-B2 | Antimicrobial compositions | MPO, NHERF1, NOX1 | MAPT 3312/4885NPC1 115/4885RAB9A 3272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.